Drugs / Amoxicillin/clavulanate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05846399 Comparator | Sep 2023 → Jul 2027 expected | cat-scratch disease | University of Missouri-Columbia | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amoxicillin/clavulanate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05846399 ↗ |
| Route | Oral | “Amoxicillin-clavulanate 875-125mg by mouth twice daily for 1 day” NCT05846399 ↗ |